Case report: rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis

HIGHLIGHTS

• who: Hosan Hasan from the University of Alberta, Canada have published the paper: Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis, in the Journal: (JOURNAL)
• what: This first-in-infant report highlights the potential benefits of the orally available prostacyclin mimetic selexipag (IP receptor agonist) as an efficient add-on PH-targeted drug in infants with severe, chronic PH. frontiersin.org 10.3389/fcvm.2022.984698

SUMMARY

The majority of aformentioned PAH-targeted drugs, including . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.